Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Human Molecular Genetics

Volumn 20, Issue 16, 2011, Pages 3304-3321

  Antoniou, Antonis C ^a   Kartsonaki, Christiana ^a   Sinilnikova, Olga M ^b,c,d   Soucy, Penny ^e   McGuffog, Lesley ^a   Healey, Sue ^f,g   Lee, Andrew ^a   Peterlongo, Paolo ^h,i   Manoukian, Siranoush ^h   Peissel, Bernard ^h   Zaffaroni, Daniela ^h,j   Cattaneo, Elisa ^h   Barile, Monica ^k   Pensotti, Valeria ^l   Pasini, Barbara ^m   Dolcetti, Riccardo ⁿ   Giannini, Giuseppe ^o   Putignano, Anna Laura ^m,p   Varesco, Liliana ^q   Radice, Paolo ^h   Mai, Phuong L ^r   Greene, Mark H ^s   Andrulis, Irene L ^t,u,v   Glendon, Gord ^w   Ozcelik, Hilmi ^t,u   Thomassen, Mads ^w   Gerdes, Anne Marie ^x   Kruse, Torben A ^w   Jensen, Uffe Birk ^y   Crüger, Dorthe G ^z   Caligo, Maria A ^aa   Laitman, Yael ^ab   Milgrom, Roni ^ab   Kaufman, Bella ^ac   Paluch Shimon, Shani ^ac   Friedman, Eitan ^ab   Loman, Niklas ^ad,ae   Harbst, Katja ^ad,ae   Lindblom, Annika ^ad,ae,ag   Arver, Brita ^ad,ae   Ehrencrona, Hans ^ad,ae,af,ef   Melin, Beatrice ^ad,ae,ag,ee   Nathanson, Katherine L ^ah   Domchek, Susan M ^ah   Rebbeck, Timothy ^ah   Jakubowska, Ania ^ai   Lubinski, Jan ^ai   Gronwald, Jacek ^ai   Huzarski, Tomasz ^ai   Byrski, Tomasz ^ai   Cybulski, Cezary ^ai   Gorski, Bohdan ^ai   Osorio, Ana ^aj,ak   Cajal, Teresa Ramón ^al   Fostira, Florentia ^am   Andrés, Raquel ^an   Benitez, Javier ^aj,ak   Hamann, Ute ^ao   Hogervorst, Frans B ^ap,as   Rookus, M A ^ap,as   Hooning, Maartje J ^aq,as   Nelen, Marcel R ^ar   van der Luijt, R B ^as   van Os, Theo A M ^as,at   van Asperen, C J ^as,au   Devilee, P ^as,au   Meijers Heijboer, H E J ^as,av   Garcia, Encarna B Gómez ^aw,ax   Peock, Susan ^a,ei   Cook, Margaret ^a,ei   Frost, Debra ^a,ei   Platte, Radka ^a,ei   Leyland, Jean ^a,ei   Evans, D Gareth ^a,ay,el   Lalloo, Fiona ^a,ay,el   Eeles, Ros ^a,az,ey   Izatt, Louise ^a,ba,el   Adlard, Julian ^a,bb,es   Davidson, Rosemarie ^a,bc,eq   Eccles, Diana ^a,bd,cn   Ong, Kai ren ^a,el   Cook, Jackie ^a,bf,el   Douglas, Fiona ^a,bg,ew   Paterson, Joan ^a,bh,en   Kennedy, M John ^a,bi,el   Miedzybrodzka, Zosia ^a,bj,ej   Godwin, Andrew ^bk   Stoppa Lyonnet, Dominique ^bl,bm,bn   Buecher, Bruno ^bl   Belotti, Muriel ^bl   Tirapo, Carole ^bl   Mazoyer, Sylvie ^d   Barjhoux, Laure ^d   Lasset, Christine ^bo,bp   Leroux, Dominique ^bq,br   Faivre, Laurence ^bs,bt   Bronner, Myriam ^bu   Prieur, Fabienne ^bv   Nogues, Catherine ^bl   Rouleau, Etienne ^bl   Pujol, Pascal ^bw,bx   Coupier, Isabelle ^bw,bx   Frénay, Marc ^by   Hopper, John L ^bz   Daly, Mary B ^ca   Terry, Mary B ^cb   John, Esther M ^cc,cd   Buys, Saundra S ^ce   Yassin, Yosuf ^cf   Miron, Alexander ^cf   Goldgar, David ^cg   Singer, Christian F ^ch   Tea, Muy Kheng ^ch   Pfeiler, Georg ^ch   Dressler, Anne Catharina ^ch   Hansen, Thomas v O ^ci   Jønson, Lars ^ci   Ejlertsen, Bent ^cj   Barkardottir, Rosa Bjork ^ck,cl   Kirchhoff, Tomas ^cm   Offit, Kenneth ^cm   Piedmonte, Marion ^cn   Rodriguez, Gustavo ^co   Small, Laurie ^cp   Boggess, John ^cq   Blank, Stephanie ^cr   Basil, Jack ^cs   Azodi, Masoud ^ct   Toland, Amanda Ewart ^cu   Montagna, Marco ^cv   Tognazzo, Silvia ^cv   Agata, Simona ^cv   Imyanitov, Evgeny ^cw   Janavicius, Ramunas ^cx,cy   Lazaro, Conxi ^cz   Blanco, Ignacio ^cz   Pharoah, Paul D P ^b   Sucheston, Lara ^df   Karlan, Beth Y ^da   Walsh, Christine S ^da   Olah, Edith ^db   Bozsik, Aniko ^db   Teo, Soo Hwang ^dc,dd   Seldon, Joyce L ^de   Beattie, Mary S ^df,dg   van Rensburg, Elizabeth J ^dh   Sluiter, Michelle D ^dh   Diez, Orland ^di,dl   Schmutzler, Rita K ^dj,dl   Wappenschmidt, Barbara ^dk,dl   Engel, Christoph ^dm   Meindl, Alfons ^dn   Ruehl, Ina ^do   Varon Mateeva, Raymonda ^dp   Kast, Karin ^dq   Deissler, Helmut ^dr   Niederacher, Dieter ^ds   Arnold, Norbert ^dt   Gadzicki, Dorothea ^du   Schönbuchner, Ines ^dv   Caldes, Trinidad ^dw   de la Hoya, Miguel ^dw   Nevanlinna, Heli ^dx   Aittomäki, Kristiina ^dx   Dumont, Martine ^e   Chiquette, Jocelyne ^e   Tischkowitz, Marc ^dy,dz   Chen, Xiaoqing ^f   Beesley, Jonathan ^f   Spurdle, Amanda B ^f   Neuhausen, Susan L ^ea   Ding, Yuan Chun ^ea   Fredericksen, Zachary ^eb   Wang, Xianshu ^eb   Pankratz, Vernon S ^eb   Couch, Fergus ^eb   Simard, Jacques ^e   Easton, Douglas F ^a   Chenevix Trench, Georgia ^f   Karlsson, Per ^ad,ae,ec   Nordling, Margareta ^ad,ae,ec   Bergman, Annika ^ad,ae,ec   Einbeigi, Zakaria ^ad,ae,ec   Stenmark Askmalm, Marie ^ad,ae,ed   Liedgren, Sigrun ^ad,ae,ed   Borg, Ake ^ad,ae   Olsson, Håkan ^ad,ae   Kristoffersson, Ulf ^ad,ae   Jernström, Helena ^ad,ae   Henriksson, Karin ^ad,ae   von Wachenfeldt, Anna ^ad,ae   Liljegren, Annelie ^ad,ae   Barbany Bustinza, Gisela ^ad,ae   Rantala, Johanna ^ad,ae   Grönberg, Henrik ^ad,ae,ee   Stattin, Eva Lena ^ad,ae,ee   Emanuelsson, Monica ^ad,ae,ee   Brandell, Richard Rosenquist ^ad,ae,ef   Dahl, Niklas ^ad,ae,ef   Verhoef, S ^ap,as   Verheus, M ^ap,as   Veer, L J van't ^ap,as   van Leeuwen, F E ^ap,as   Collee M ^aq,as   van den Ouweland, A M W ^aq,as   Jager, A ^aq,as   Tilanus Linthorst, M M A ^aq,as   Seynaeve, C ^aq,as   Wijnen, J T ^as,au   Vreeswijk, M P ^as,au   Tollenaar, R A ^as,au   Ligtenberg, M J ^ar,as   Hoogerbrugge, N ^ar,as   Ausems, M G ^as   Aalfs, C M ^as,at   Gille, J J P ^as,av   Waisfisz, Q ^as,av   Gomez Garcia, E B ^as,ax   van Roozendaal, C E ^as,ax   Blok, Marinus J ^as,ax   Caanen, B ^as,ax   Oosterwijk, J C ^as,eg   van der Hout, A H ^as,eg   Mourits, M J ^as,eg   Vasen, H F ^as,eh   Gregory, Helen ^a,ej   Morrison, Patrick ^a,ek   Jeffers, Lisa ^a,ek   Cole, Trevor ^a,el   McKeown, Carole ^a,el   Hoffman, Jonathan ^a,el   Donaldson, Alan ^a,em   Downing, Sarah ^a,en   Taylor, Amy ^a,en   Murray, Alexandra ^a,bi   Rogers, Mark T ^a,bi   McCann, Emma ^a,bi   Barton, David ^a,el   Porteous, Mary ^a,eo   Drummond, Sarah ^a,eo   Brewer, Carole ^a,ep   Kivuva, Emma ^a,ep   Searle, Anne ^a,ep   Goodman, Selina ^a,ep   Hill, Kathryn ^a,ep   Murday, Victoria ^a,eq   Bradshaw, Nicola ^a,eq   Snadden, Lesley ^a,eq   Longmuir, Mark ^a,eq   Watt, Catherine ^a,eq   Gibson, Sarah ^a,eq   Haque, Eshika ^a,eq   Tobias, Ed ^a,eq   Duncan, Alexis ^a,eq   Jacobs, Chris ^a,el   Langman, Caroline ^a,el   Whaite, Anna ^a,el   Dorkins, Huw ^a,er   Barwell, Julian ^a,bb   Chu, Carol ^a,es   Miller, Julie ^a,es   Ellis, Ian ^a,et   Houghton, Catherine ^a,et   Taylor, Jane ^a,el   Side, Lucy ^a,eu   Male, Alison ^a,eu   Berlin, Cheryl ^a,eu   Eason, Jacqueline ^a,ev   Collier, Rebecca ^a,ev   Claber, Oonagh ^a,ew   Jobson, Irene ^a,ew   Walker, Lisa ^a,ex   McLeod, Diane ^a,ex   Halliday, Dorothy ^a,ex   Durell, Sarah ^a,ex   Stayner, Barbara ^a,ex   Shanley, Susan ^a,ey   Rahman, Nazneen ^a,ey   Houlston, Richard ^a,ey   Bancroft, Elizabeth ^a,ey   D'Mello, Lucia ^a,ey   Page, Elizabeth ^a,ey   Ardern Jones, Audrey ^a,ey   Kohut, Kelly ^a,ey   Wiggins, Jennifer ^a,ey   Castro, Elena ^a,ey   Mitra, Anita ^a,ey   Robertson, Lisa ^a,ey   Quarrell, Oliver ^a,el   Bardsley, Cathryn ^a,el   Hodgson, Shirley ^a,bd   Goff, Sheila ^a,bd   Brice, Glen ^a,bd   Winchester, Lizzie ^a,bd   Eddy, Charlotte ^a,bd   Tripathi, Vishakha ^a,bd   Attard, Virginia ^a,bd   Lucassen, Anneke ^a,cn   Crawford, Gillian ^a,cn   McBride, Donna ^a,cn   Smalley, Sarah ^a,cn   more..

^a Division of Cancer Epidemiology and Genetics   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

^e LAVAL UNIVERSITY   (Canada)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g PETER MACCALLUM CANCER CENTRE   (Australia)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^j UNIVERSITY OF MILAN   (Italy)

^k EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^l IFOM IEO Campus   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p UNIVERSITY OF FLORENCE   (Italy)

^q Fiorgen Foundation for Pharmacogenomics   (Italy)

^r UNIVERSITY OF GENOA   (Italy)

^s NATIONAL CANCER INSTITUTE   (United States)

^t MOUNT SINAI HOSPITAL   (Canada)

^u UNIVERSITY OF TORONTO   (Canada)

^v CANCER CARE ONTARIO   (Canada)

^w ODENSE UNIVERSITY HOSPITAL   (Denmark)

^x Clinical Genetics   (Denmark)

^y AARHUS UNIVERSITY HOSPITAL   (Denmark)

^z LILLEBAELT HOSPITAL   (Denmark)

^aa UNIVERSITY HOSPITAL OF PISA   (Italy)

^ab GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^ac SHEBA MEDICAL CENTER   (Israel)

^ad LUND UNIVERSITY HOSPITAL   (Sweden)

^ae KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^af UPPSALA UNIVERSITY   (Sweden)

^ag UMEÅ UNIVERSITY   (Sweden)

^ah UNIVERSITY OF PENNSYLVANIA   (United States)

^ai POMERANIAN MEDICAL UNIVERSITY   (Poland)

^aj Centro Nacional de Investigaciones Oncológicas   (Spain)

^ak CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^al HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^am INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^an HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^ao GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ap NETHERLANDS CANCER INSTITUTE   (Netherlands)

^aq ERASMUS MEDICAL CENTER   (Netherlands)

^ar RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^as UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^at ACADEMIC MEDICAL CENTER   (Netherlands)

^au LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^av VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^aw GROW Research Institute for Oncology and Developmental Biology   (Netherlands)

^ax MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^ay UNIVERSITY OF MANCHESTER   (United Kingdom)

^az INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ba GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^bb Yorkshire Regional Genetics Service   (United Kingdom)

^bc ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^bd PRINCESS ANNE HOSPITAL   (United Kingdom)

^be BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^bf SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^bg NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^bh ADDENBROOKE S HOSPITAL   (United Kingdom)

^bi ST JAMES S HOSPITAL   (Ireland)

^bj UNIVERSITY OF ABERDEEN   (United Kingdom)

^bk UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^bl INSTITUT CURIE   (France)

^bm INSTITUT CURIE   (France)

^bn UNIVERSITÉ PARIS DESCARTES   (France)

^bo UNIVERSITÉ LYON 1   (France)

^bp CENTRE LÉON BÉRARD   (France)

^bq GRENOBLE UNIVERSITY HOSPITAL   (France)

^br UNIV GRENOBLE ALPES   (France)

^bs DIJON UNIVERSITY HOSPITAL   (France)

^bt Center de Lutte Contre le Cancer Georges François Leclerc   (France)

^bu UNIVERSITÉ DE LORRAINE   (France)

^bv UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^bw HÔPITAL ARNAUD DE VILLENEUVE   (France)

^bx CENTRE VAL D AURELLE   (France)

^by CENTRE ANTOINE LACASSAGNE   (France)

^bz UNIVERSITY OF MELBOURNE   (Australia)

^ca FOX CHASE CANCER CENTER   (United States)

^cb Och Spine at New York Presbyterian Hospitals   (United States)

^cc NORTHERN CALIFORNIA CANCER CENTER   (United States)

^cd STANFORD CANCER INSTITUTE   (United States)

^ce UNIVERSITY OF UTAH   (United States)

^cf DANA FARBER CANCER INSTITUTE   (United States)

^cg UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ch MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ci Mental Health Services CPH   (Denmark)

^cj Rigshospitalet   (Denmark)

^ck UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^cl UNIVERSITY OF ICELAND   (Iceland)

^cm MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^cn ROSWELL PARK CANCER INSTITUTE   (United States)

^co EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^cp MAINE MEDICAL CENTER   (United States)

^cq UNIVERSITY OF NORTH CAROLINA   (United States)

^cr NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^cs St Elizabeth Medical Center   (United States)

^ct YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^cu OHIO STATE UNIVERSITY   (United States)

^cv VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^cw N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^cx VILNIUS UNIVERSITY   (Lithuania)

^cy State Research Institute Innovative Medicine Center   (Lithuania)

^cz CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^da CEDARS SINAI MEDICAL CENTER   (United States)

^db NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^dc CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^dd UNIVERSITY OF MALAYA   (Malaysia)

^de UNIVERSITY OF CALIFORNIA   (United States)

^df UNIVERSITY OF CALIFORNIA   (United States)

^dg UNIVERSITY OF CALIFORNIA   (United States)

^dh UNIVERSITY OF PRETORIA   (South Africa)

^di HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^dj VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^dk Department of Gynaecology and Obstetrics   (Germany)

^dl UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^dm UNIVERSITY OF LEIPZIG   (Germany)

^dn TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^do UNIVERSITY OF MUNICH   (Germany)

^dp CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^dq UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^dr UNIVERSITY HOSPITAL ULM   (Germany)

^ds UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^dt UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^du HANNOVER MEDICAL SCHOOL   (Germany)

^dv UNIVERSITY OF WÜRZBURG   (Germany)

^dw HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^dx HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^dy MCGILL UNIVERSITY   (Canada)

^dz MCGILL UNIVERSITY   (Canada)

^ea CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^eb MAYO CLINIC   (United States)

^ec SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ed LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^ee UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^ef UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^eg UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^eh Foundation for the Detection of Hereditary Tumours   (Netherlands)

^ei North of Scotland Regional Genetics Service   (United Kingdom)

^ej Northern Ireland Regional Genetics Service   (United Kingdom)

^ek West Midlands Regional Clinical Genetics Service   (United Kingdom)

^el University Medical Center Utrecht ^*  (United Kingdom)

^em East Anglian Regional Genetics Service   (United Kingdom)

^en Medical Genetics Services for Wales   (United Kingdom)

^eo Peninsula Clinical Genetics Service   (United Kingdom)

^ep West of Scotland Regional Genetics Service   (United Kingdom)

^eq GUY S HOSPITAL   (United Kingdom)

^er Leicestershire Clinical Genetics Service   (United Kingdom)

^es Merseyside and Cheshire Clinical Genetics Service   (United Kingdom)

^et Manchester Regional Genetics Service   (United Kingdom)

^eu NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^ev Northern Clinical Genetics Service   (United Kingdom)

^ew Oxford Regional Genetics Service   (United Kingdom)

^ex INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ey North Trent Clinical Genetics Service   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960819760     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr226     Document Type: Article

References (43)

1. Wood, M., Yin, H. and McClorey, G. (2007) Modulating the expression of disease genes with RNA-based therapy. PLoS Genet., 3, e109.
2. Artsma-Rus, A., Fokkema, I., Verschuuren, J., Ginjaar, I., van Deutekom, D.J., van Ommen, G.J. and den Dunnen, J.T. (2009) Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum. Mutat., 30, 293-299.
3. Du, L. and Gatti, R.A. (2009) Progress toward therapy with antisense-mediated splicing modulation. Curr. Opin. Mol. Ther., 11, 116-123.
4. Du, L. and Gatti, R.A. (2011) Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases. J. Immunol. Methods, 365,1-7.
5. Gatti, R.A. (2001) Ataxia-telangiectasia. In Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, pp. 705-732.
6. Lavin, M.F. (2008) Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol., 9, 759-769.
7. Lee, J.H. and Paull, T.T. (2007) Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene, 26, 7741-7748.
8. Lavin, M.F., Kozlov, S., Gueven, N., Peng, C., Birrell, G., Chen, P. and Scott, S. (2005) Atm and cellular response to DNA damage. Adv. Exp. Med. Biol., 570, 457-476.
9. Lavin, M.F., Gueven, N., Bottle, S. and Gatti, R.A. (2007) Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br. Med. Bull., 81/82, 129-147.
10. Du, L., Pollard, J.M. and Gatti, R.A. (2007) Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides. Proc. Natl Acad. Sci. USA, 104, 6007-6012.
11. Vinters, H.V., Gatti, R.A. and Rakic, P. (1985) Sequence of cellular events in cerebellar ontogeny relevant to expression of neuronal abnormalities in ataxia-telangiectasia. Kroc. Found. Ser., 19, 233-255.
12. Gatti, R.A. and Vinters, H.V. (1985) Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc. Found. Ser., 19, 225-232.
13. Foged, C. and Nielsen, H.M. (2008) Cell-penetrating peptides for drug delivery across membrane barriers. Expert. Opin. Drug Deliv., 5, 105-117.
14. Lebleu, B., Moulton, H.M., Abes, R., Ivanova, G.D., Abes, S., Stein, D.A., Iversen, P.L., Arzumanov, A.A. and Gait, M.J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv. Drug Deliv. Rev., 60, 517-529.
15. Marshall, N.B., Oda, S.K., London, C.A., Moulton, H.M., Iversen, P.L., Kerkvliet, N.I. and Mourich, D.V. (2007) Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing. J. Immunol. Methods, 325, 114-126.
16. El-Andaloussi, S., Johansson, H.J., Holm, T. and Langel, U. (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol. Ther., 15, 1820-1826.
17. Abes, R., Arzumanov, A., Moulton, H., Abes, S., Ivanova, G., Gait, M.J., Iversen, P. and Lebleu, B. (2008) Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J. Pept. Sci., 14, 455-460.
18. Lehto, T., Abes, R., Oskolkov, N., Suhorutsenko, J., Copolovici, D.M., Mager, I., Viola, J.R., Simonson, O.E., Ezzat, K., Guterstam, P. et al. (2010) Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. J. Control Release, 141, 42-51.
19. Amantana, A., Moulton, H.M., Cate,M.L.,Reddy,M.T.,Whitehead,T., Hassinger, J.N., Youngblood, D.S. and Iversen, P.L. (2007) Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug. Chem., 18, 1325-1331.
20. Fletcher, S., Honeyman, K., Fall, A.M., Harding, P.L., Johnsen, R.D., Steinhaus, J.P., Moulton, H.M., Iversen, P.L. and Wilton, S.D. (2007) Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol. Ther., 15, 1587-1592.
21. Yin, H., Moulton, H.M., Seow, Y., Boyd, C., Boutilier, J., Iverson, P. and Wood, M.J. (2008) Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum. Mol. Genet., 17, 3909-3918.
22. Wu, B., Moulton, H.M., Iversen, P.L., Jiang, J., Li, J., Li, J., Spurney, C.F., Sali, A., Guerron, A.D., Nagaraju, K. et al. (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc. Natl Acad. Sci. USA, 105, 14814-14819.
23. Eng, L., Coutinho, G., Nahas, S., Yeo, G., Tanouye, R., Babaei, M., Dork, T., Burge, C. and Gatti, R.A. (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene: maximum entropy estimates of splice junction strengths. Hum. Mutat., 23, 67-76.
24. Coutinho, G., Xie, J., Du, L., Brusco, A., Krainer, A.R. and Gatti, R.A. (2005) Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a. Hum. Mutat., 25, 118-124.
25. Mitui, M., Campbell, C., Coutinho, G., Sun, X., Lai, C.H., Thorstenson, Y., Castellvi-Bel, S., Fernandez, L., Monros, E., Carvalho, B.T. et al. (2003) Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate. Hum. Mutat., 22, 43-50.
26. Kim, S.T., Xu, B. and Kastan, M.B. (2002) Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev., 16, 560-570.
27. Li, X., Lee, Y.K., Jeng, J.C., Yen, Y., Schultz, D.C., Shih, H.M. and Ann, D.K. (2007) Role for KAP1 serine 824 phosphorylation and sumoylation/ desumoylation switch in regulating KAP1-mediated transcriptional repression. J. Biol. Chem., 282, 36177-36189.
28. Du, L., Damoiseaux, R., Nahas, S., Gao, K., Hu, H., Pollard, J.M., Goldstine, J., Jung, M.E., Henning, S.M., Bertoni, C. and Gatti, R.A. (2009) Nonaminoglycoside compounds induce readthrough of nonsense mutations. J. Exp. Med., 206, 2285-2297.
29. Sun, X., Becker-Catania, S.G., Chun, H.H., Hwang, M.J., Huo, Y., Wang, Z., Mitui, M., Sanal, O., Chessa, L., Crandall, B. and Gatti, R.A. (2002) Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. J. Pediatr., 140, 724-731.
30. Bastianelli, E. (2003) Distribution of calcium-binding proteins in the cerebellum. Cerebellum, 2, 242-262.
31. Amantana, A. and Iversen, P.L. (2005) Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers. Curr. Opin. Pharmacol., 5, 550-555.
32. Arora, V., Devi, G.R. and Iversen, P.L. (2004) Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics. Curr. Pharm. Biotechnol., 5, 431-439.
33. Iversen, P.L., Aird, K.M., Wu, R., Morse, M.M. and Devi, G.R. (2009) Cellular uptake of neutral phosphorodiamidate morpholino oligomers. Curr. Pharm. Biotechnol., 10, 579-588.
34. Morcos, P.A. (2007) Achieving targeted and quantifiable alteration of mRNA splicing with morpholino oligos. Biochem. Biophys. Res. Commun., 358, 521-527.
35. Asai, H., Hirano, M., Kiriyama, T., Ikeda, M. and Ueno, S. (2010) Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism. Biochem. Biophys. Res. Commun., 391, 800-805
36. Garcia-Blanco, M.A., Baraniak, A.P. and Lasda, E.L. (2004) Alternative splicing in disease and therapy. Nat. Biotechnol., 22, 535-546.
37. Abes, S., Moulton, H.M., Clair, P., Prevot, P., Youngblood, D.S., Wu, R.P., Iversen, P.L. and Lebleu, B. (2006) Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control Release, 116, 304-313.
38. Youngblood, D.S., Hatlevig, S.A., Hassinger, J.N., Iversen, P.L. and Moulton, H.M. (2007) Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem., 18, 50-60.
39. Jearawiriyapaisarn, N., Moulton, H.M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P.L. and Kole, R. (2008) Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol. Ther., 16, 1624-1629.
40. Gatti, R.A., Becker-Catania, S., Chun, H.H., Sun, X., Mitui, M., Lai, C.H., Khanlou, N., Babaei, M., Cheng, R., Clark, C. et al. (2001) The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone. Clin. Rev. Allergy Immunol., 20, 87-108.
41. Trehin, R. and Merkle, H.P. (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm., 58, 209-223.
42. Butch, A.W., Chun, H.H., Nahas, S.A. and Gatti, R.A. (2004) Immunoassay to measure ataxia-telangiectasia mutated protein in cellular lysates. Clin. Chem., 50, 2302-2308.
43. Chun, H.H., Cary, R.B., Lansigan, F., Whitelegge, J., Rawlings, D.J. and Gatti, R.A. (2004) ATM protein purified from vaccinia virus expression system: DNA binding requirements for kinase activation. Biochem. Biophys. Res. Commun., 322, 74-81.